COO −15%+: FY guide cut, CVI inventory drag — Surgical retained
Posted: Thu Sep 10, 2026 6:17 pm
Cooper Companies (COO) is the medical-device guide-cut of the day: ~−15–17% after AMC Wednesday into Thursday RTH.
Key numbers (fair paraphrase): Q3 revenue ~$1.07B vs ~$1.10B Street; adj EPS ~$1.15 vs ~$1.12. FY26 revenue cut to $4.229–4.252B (from $4.285–4.321B); adj EPS $4.51–4.55 (from $4.58–4.66). Q4 guide $1.057–1.080B / $1.05–1.09 EPS — both below prior Street. Driver called out: CooperVision U.S. channel inventory reduction weighing on Q3 and still into Q4. Board finished strategic review and kept CooperSurgical; buyback auth lifted $2B → $3B.
Scalper notes:
- This is a multiple reset on forward growth, not a one-print gap-and-go — size as reaction trade off first RTH levels
- Watch whether ALGN/XRAY/HSIC echo elective/vision softness vs COO-specific inventory clean-up
- Buyback expansion is noise until the tape stops making lower highs
Source (fair paraphrase): https://www.reuters.com/business/cooper ... 026-09-09/
Fading the flush on buyback + Surgical keep, or waiting for CVI organic to stop going negative?
Which level matters more into the close — VWAP or the AMC gap fill?
Key numbers (fair paraphrase): Q3 revenue ~$1.07B vs ~$1.10B Street; adj EPS ~$1.15 vs ~$1.12. FY26 revenue cut to $4.229–4.252B (from $4.285–4.321B); adj EPS $4.51–4.55 (from $4.58–4.66). Q4 guide $1.057–1.080B / $1.05–1.09 EPS — both below prior Street. Driver called out: CooperVision U.S. channel inventory reduction weighing on Q3 and still into Q4. Board finished strategic review and kept CooperSurgical; buyback auth lifted $2B → $3B.
Scalper notes:
- This is a multiple reset on forward growth, not a one-print gap-and-go — size as reaction trade off first RTH levels
- Watch whether ALGN/XRAY/HSIC echo elective/vision softness vs COO-specific inventory clean-up
- Buyback expansion is noise until the tape stops making lower highs
Source (fair paraphrase): https://www.reuters.com/business/cooper ... 026-09-09/
Fading the flush on buyback + Surgical keep, or waiting for CVI organic to stop going negative?
Which level matters more into the close — VWAP or the AMC gap fill?